Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. - Wikidata - wikimedia - TriplyDB

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.

http://www.wikidata.org/entity/Q34114943

about

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.Role of postmastectomy radiotherapy in early-stage (T1-2N0-1M0) triple-negative breast cancer: a systematic review.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Optimal approach in early breast cancer: Radiation therapy The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.Implications of High Rates of Metastatic Prostate Cancer in BRCA2 Mutation Carriers High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diag Morphological predictors of BRCA1 germline mutations in young women with breast cancer.BRCA mutation testing in determining breast cancer therapy.Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.Nipple-sparing mastectomy in patients with BRCA1/2 mutations and variants of uncertain significance.BRCA1 Mutation: A Predictive Marker for Radiation Therapy?Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer.Managing the breast in patients who test positive for hereditary breast cancer.Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.Genetic testing today.Breast cancer under age 40: a different approach.Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.Surgical Treatment of Breast Cancer in BRCA-Mutation Carriers.Management of hereditary breast and ovarian cancer.Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.Genetic testing in women with breast cancer: implications for treatment.The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition.Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations.Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.Oncology health professionals' attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer.BRCA1/2 testing: therapeutic implications for breast cancer management BRCA in breast cancer: ESMO Clinical Practice Guidelines

P2860

Q30410984-ED424F95-D207-4823-AA74-8B410ABA82E9 Q33553668-4174511B-942A-4974-9D71-DDB591D03789 Q33564013-CCB03444-5C11-47DD-B1E6-9E61956690D7 Q33699050-49848D2E-55A0-416E-9AE7-67F05F16E578 Q33739428-CB549729-9A2C-47F4-9310-9CCEAD8FC1A0 Q33796352-44E2D0D4-093D-43D8-8F30-69378DB7DC99 Q34240064-3994A150-FB44-4C4F-9586-1E18FF16D072 Q34354159-3FE234E1-86AE-4C66-9F3B-CA33D1B12E0B Q34727284-71398455-2912-4731-A0E2-C6D5EAD2A9B5 Q35619225-5997B628-35D5-4DB3-BC4F-6080725F772B Q35684391-7F228723-EB3C-4416-9A62-98C3846F96F2 Q35983751-88BE3600-6966-4F7A-BE22-7860F81119B6 Q36048064-566AE4AA-AF83-46FB-9458-7AC5AFA33044 Q36076772-48E84A10-9E18-426D-A7F0-8CCF33DB06A3 Q36210166-CA38A341-F59A-4974-AE1E-1F570877C529 Q37609525-231362A1-A245-45A5-8F52-E6266A4A75BA Q37991240-4EA33A3C-76A9-4742-81CB-722F96BD476A Q38190905-40D70DF8-D5B1-4279-96E4-56EBE0433A6B Q38230196-DC08A4FA-CFCC-425E-B54B-47BEDE4A26CC Q38386346-79A657E2-640E-4A74-98BF-C087CDF914D2 Q39659182-F08C2C30-C910-482D-A3D4-E8CF46A7D936 Q42316325-DBEADC02-17AA-456A-8BD4-84490D1051E9 Q47399250-AD949EE5-EF07-45E5-863D-C5299103A1FA Q47880061-E5D2994F-186D-4F22-9D84-8EC0F0321E53 Q47884776-44099C3A-7A32-4ECB-B655-17C2168D95BC Q48901665-0AED46C4-8882-4C68-95C9-943497D04F1F Q49936982-01317886-7831-459E-BCD4-EB0390CF8AF1 Q50860439-09F9E0B0-BC9E-43BD-83CC-D0D8E5E79B17 Q51157118-60B8DD03-B81F-4314-AD1D-5A4AFF6980E9 Q51245901-FD98D1D8-B5FA-4CDB-950D-1F737BD19A23 Q54257613-2B00801F-1D22-4D5C-92D6-EC3976ECD228 Q57110101-8EFB8CC7-5AB1-4060-BE32-54CCB1FA2A3E Q59274104-F59679A8-50B2-4C46-83E5-9B96901E56B8

P2860

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.

http://www.wikidata.org/entity/Q34114943

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@ast

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@en

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@nl

type

label

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@ast

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@en

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@nl

prefLabel

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@ast

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@en

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@nl

P1433

Q34114943-72E6AB81-DE5B-455F-B3B7-B46EA912FD59

P1476

Q34114943-F4BD08D0-A567-4506-A30E-5AADACADEF48

P2093

Q34114943-0472FA4A-DCB0-4017-87A5-647ED22C6006

Q34114943-2AE7F665-330A-4FAD-BE3A-A6D428D9A4FA

Q34114943-444208BD-1D0A-4EAF-82F0-8C2FED7DA563

Q34114943-445FD782-75E6-4BDE-B02C-694F51F562B1

Q34114943-5D4307A5-552E-4E02-9AAB-EDF4BD9899CC

Q34114943-6395DBF3-E9CE-4A43-B91D-ED68A5E1912D

Q34114943-8518F4F4-6323-4032-92CD-381EA0C84B9F

Q34114943-8DD7C157-D433-45D1-953A-A216DB849AAA

Q34114943-9618C852-7591-44C4-8099-BC9221946405

Q34114943-E4B574E6-51C5-4DD8-84F3-911A0B17F492

P2860

Q34114943-0AF17F10-62B5-4885-B342-179D9282497B

Q34114943-1A8B8208-BDA7-4AF9-8B50-F580F5A89C24

Q34114943-21D36A78-03C7-4300-89B3-639DE0CB2FF4

Q34114943-2EFE10EC-2606-43D6-AEBC-594AF956FB6A

Q34114943-3A61E612-5CBF-428B-8B83-3398868A602D

Q34114943-40425834-AB9E-4B0F-B827-9964B8C9CB26

Q34114943-5893C823-793B-40C2-8BF3-1AC9545717C6

Q34114943-5FF83DAE-0F27-4B22-B080-BD009E7AB88A

Q34114943-63272AE8-F3C7-4EB8-8E25-D92620D46933

Q34114943-843DF2F9-1521-4708-B073-D45FADD884CB

P2888

Q34114943-9FF278DA-5068-4ED7-8518-707372B0A2D6

P304

Q34114943-516E38B1-9D20-4783-8900-218C7D76C843

P31

Q34114943-451EE0EB-63FC-4F6B-B138-8224939D42CE

P356

Q34114943-BD298B72-2DC5-49AD-905D-9656A48F4D8A

P407

Q34114943-F5F94F54-0188-4F12-A0E3-D8A84691CDDD

P433

Q34114943-997D85CA-08AE-47E7-946C-FAB0D377833D

P478

Q34114943-BA25DF2E-567C-4522-863A-7B94CB017F49

P50

Q34114943-A94942DD-5DB7-495B-B5A5-982017ECFFAD

Q34114943-BCC68477-5A4A-42FF-852A-42D80FAC9FC5

Q34114943-BD6A9F37-066D-4C5D-826B-272BCE635197

P577

Q34114943-DC7B9385-051B-4C43-8AE6-CAF0600316E5

P5875

Q34114943-63949357-E326-4135-9113-6E936C3A261D

P6179

Q34114943-9DAA5C0D-71DD-4933-8361-092206D282AE

P698

Q34114943-6CD1942A-4D10-4442-8B46-C56B202FEDE1

P932

Q34114943-57F1F97F-81A0-43F3-B9D8-64E49C03C95B

P356

S10549-010-0894-Z

P1433

Breast Cancer Research and Treatment

P1476

Local therapy in BRCA1 and BRC ...... t conservation and mastectomy.

@en

P2093

Amichay Meirovitz

http://www.w3.org/2001/XMLSchema#string

Bella Kaufman

http://www.w3.org/2001/XMLSchema#string

Bruce G Haffty

http://www.w3.org/2001/XMLSchema#string

David K Gaffney

http://www.w3.org/2001/XMLSchema#string

Judy E Garber

http://www.w3.org/2001/XMLSchema#string

Kent A Griffith

http://www.w3.org/2001/XMLSchema#string

Lori J Pierce

http://www.w3.org/2001/XMLSchema#string

Meena S Moran

http://www.w3.org/2001/XMLSchema#string

Merav Ben-David

http://www.w3.org/2001/XMLSchema#string

Saundra Buys

http://www.w3.org/2001/XMLSchema#string

P2860

Variation of breast cancer risk among BRCA1/2 carriers.

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy.

Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

P2888

s10549-010-0894-z

P304

389-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-010-0894-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Kelly-Anne Phillips

Judith Balmaña

Susan M Domchek

P577

2010-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43248449

http://www.w3.org/2001/XMLSchema#string

P6179

1020303488

http://www.w3.org/2001/XMLSchema#string

P698

20411323

http://www.w3.org/2001/XMLSchema#string

P932

2936479

http://www.w3.org/2001/XMLSchema#string